Year |
Citation |
Score |
2023 |
Mathai DS, Hilbert S, Sepeda ND, Strickland JC, Griffiths RR, Garcia-Romeu A. Double-Blind Comparison of the Two Hallucinogens Dextromethorphan and Psilocybin: Experience-Dependent and Enduring Psychological Effects in Healthy Volunteers. Psychedelic Medicine (New Rochelle, N.Y.). 1: 241-252. PMID 38152462 DOI: 10.1089/psymed.2023.0035 |
0.509 |
|
2023 |
Yaden DB, Berghella AP, Hendricks PS, Yaden ME, Levine M, Rohde J, Nayak S, Johnson MW, Garcia-Romeu A. IUPHAR-review: The Integration of Classic Psychedelics into Current Substance Use Disorder Treatment Models. Pharmacological Research. 106998. PMID 38029805 DOI: 10.1016/j.phrs.2023.106998 |
0.453 |
|
2023 |
Nayak SM, Jackson H, Sepeda ND, Mathai DS, So S, Yaffe A, Zaki H, Brasher TJ, Lowe MX, Jolly DRP, Barrett FS, Griffiths RR, Strickland JC, Johnson MW, Jackson H, ... Garcia-Romeu A, et al. Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey. Frontiers in Psychiatry. 14: 1199642. PMID 37795509 DOI: 10.3389/fpsyt.2023.1199642 |
0.706 |
|
2023 |
Henningfield JE, Chawarski MC, Garcia-Romeu A, Grundmann O, Harun N, Hassan Z, McCurdy CR, McMahon LR, Sharma A, Shoaib M, Singh D, Smith KE, Swogger MT, Vicknasingam B, Walsh Z, et al. Kratom withdrawal: Discussions and conclusions of a scientific expert forum. Drug and Alcohol Dependence Reports. 7: 100142. PMID 37397437 DOI: 10.1016/j.dadr.2023.100142 |
0.42 |
|
2022 |
Smith KE, Dunn KE, Epstein DH, Feldman JD, Garcia-Romeu A, Grundmann O, Henningfield JE, McCurdy CR, Rogers JM, Schriefer D, Singh D, Weiss ST. Need for clarity and context in case reports on kratom use, assessment, and intervention. Substance Abuse. 43: 1221-1224. PMID 35657649 DOI: 10.1080/08897077.2022.2074608 |
0.459 |
|
2022 |
Swogger MT, Smith KE, Garcia-Romeu A, Grundmann O, Veltri CA, Henningfield JE, Busch LY. Understanding Kratom Use: A Guide for Healthcare Providers. Frontiers in Pharmacology. 13: 801855. PMID 35308216 DOI: 10.3389/fphar.2022.801855 |
0.458 |
|
2022 |
Henningfield JE, Grundmann O, Garcia-Romeu A, Swogger MT. We Need Better Estimates of Kratom Use Prevalence. American Journal of Preventive Medicine. 62: 132-133. PMID 34922651 DOI: 10.1016/j.amepre.2021.07.022 |
0.404 |
|
2021 |
Bobe JR, Jutras BL, Horn EJ, Embers ME, Bailey A, Moritz RL, Zhang Y, Soloski MJ, Ostfeld RS, Marconi RT, Aucott J, Ma'ayan A, Keesing F, Lewis K, Ben Mamoun C, ... ... Garcia-Romeu A, et al. Recent Progress in Lyme Disease and Remaining Challenges. Frontiers in Medicine. 8: 666554. PMID 34485323 DOI: 10.3389/fmed.2021.666554 |
0.495 |
|
2021 |
Yaden DB, Berghella AP, Regier PS, Garcia-Romeu A, Johnson MW, Hendricks PS. Classic psychedelics in the treatment of substance use disorder: Potential synergies with twelve-step programs. The International Journal On Drug Policy. 98: 103380. PMID 34329952 DOI: 10.1016/j.drugpo.2021.103380 |
0.471 |
|
2021 |
Strickland JC, Garcia-Romeu A, Johnson MW. Correction to Set and Setting: A Randomized Study of Different Musical Genres in Supporting Psychedelic Therapy. Acs Pharmacology & Translational Science. 4: 1248. PMID 34151215 DOI: 10.1021/acsptsci.1c00119 |
0.379 |
|
2021 |
Cox DJ, Garcia-Romeu A, Johnson MW. Predicting changes in substance use following psychedelic experiences: natural language processing of psychedelic session narratives. The American Journal of Drug and Alcohol Abuse. 1-11. PMID 34096403 DOI: 10.1080/00952990.2021.1910830 |
0.451 |
|
2021 |
Yaden DB, Johnson MW, Griffiths RR, Doss M, Garcia-Romeu A, Nayak S, Gukasayan N, Mathur BN, Barrett FS. Psychedelics and Consciousness: Distinctions, Demarcations, and Opportunities. The International Journal of Neuropsychopharmacology. PMID 33987652 DOI: 10.1093/ijnp/pyab026 |
0.691 |
|
2021 |
Strickland JC, Garcia-Romeu A, Johnson MW. Set and Setting: A Randomized Study of Different Musical Genres in Supporting Psychedelic Therapy. Acs Pharmacology & Translational Science. 4: 472-478. PMID 33860177 DOI: 10.1021/acsptsci.0c00187 |
0.516 |
|
2021 |
Garcia-Romeu A, Barrett FS, Carbonaro TM, Johnson MW, Griffiths RR. Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches. Journal of Psychopharmacology (Oxford, England). 269881121991822. PMID 33611977 DOI: 10.1177/0269881121991822 |
0.69 |
|
2021 |
Henningfield JE, Fields S, Anthony JC, Brown LS, Bolaños-Guzmán CA, Comer SD, De La Garza R, Furr-Holden D, Garcia-Romeu A, Hatsukami D, Raznahan A, Zarate CA. Reply to Drs. Hart and Cadet: we agree-the challenges of increasing equity, diversity and inclusion include societal issues and actions now are vital. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 33558676 DOI: 10.1038/s41386-020-00921-3 |
0.403 |
|
2020 |
Singh D, Brown PN, Cinosi E, Corazza O, Henningfield JE, Garcia-Romeu A, McCurdy CR, McMahon LR, Prozialeck WC, Smith KE, Swogger MT, Veltri C, Walsh Z, Grundmann O. Current and Future Potential Impact of COVID-19 on Kratom ( Korth.) Supply and Use. Frontiers in Psychiatry. 11: 574483. PMID 33324252 DOI: 10.3389/fpsyt.2020.574483 |
0.5 |
|
2020 |
Henningfield JE, Fields S, Anthony JC, Brown LS, Bolaños-Guzmán CA, Comer SD, De La Garza R, Furr-Holden D, Garcia-Romeu A, Hatsukami D, Raznahan A, Zarate CA. Advancing equity, diversity, and inclusion in the American College of Neuropsychopharmacology (ACNP): advances, challenges, and opportunities to accelerate progress. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 32746445 DOI: 10.1038/S41386-020-0784-Y |
0.479 |
|
2020 |
Grundmann O, Babin JK, Henningfield JE, Garcia-Romeu A, Kruegel AC, Prozialeck WC, Raffa RB, Singh D, Smith KE. Kratom Use in the United States: A Diverse and Complex Profile. Addiction (Abingdon, England). PMID 32602213 DOI: 10.1111/Add.15173 |
0.388 |
|
2020 |
Garcia-Romeu A, Cox DJ, Smith KE, Dunn KE, Griffiths RR. Kratom (Mitragyna speciosa): User demographics, use patterns, and implications for the opioid epidemic. Drug and Alcohol Dependence. 107849. PMID 32029298 DOI: 10.1016/J.Drugalcdep.2020.107849 |
0.727 |
|
2019 |
Garcia-Romeu A, Davis AK, Erowid E, Erowid F, Griffiths RR, Johnson MW. Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey. Frontiers in Psychiatry. 10: 955. PMID 32038317 DOI: 10.3389/Fpsyt.2019.00955 |
0.65 |
|
2019 |
Garcia-Romeu A, Davis AK, Erowid F, Erowid E, Griffiths RR, Johnson MW. Cessation and reduction in alcohol consumption and misuse after psychedelic use. Journal of Psychopharmacology (Oxford, England). 269881119845793. PMID 31084460 DOI: 10.1177/0269881119845793 |
0.635 |
|
2018 |
Garcia-Romeu A, Richards WA. Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions. International Review of Psychiatry (Abingdon, England). 1-26. PMID 30422079 DOI: 10.1080/09540261.2018.1486289 |
0.346 |
|
2018 |
Noorani T, Garcia-Romeu A, Swift TC, Griffiths RR, Johnson MW. Psychedelic therapy for smoking cessation: Qualitative analysis of participant accounts. Journal of Psychopharmacology (Oxford, England). 269881118780612. PMID 29938565 DOI: 10.1177/0269881118780612 |
0.681 |
|
2018 |
McKenna M, Fedota J, Garcia-Romeu A, Johnson M, Griffiths R, Stein E. T263. Psilocybin Improves Cognitive Control and Downregulates Parietal Cortex in Treatment-Seeking Smokers Biological Psychiatry. 83: S231-S232. DOI: 10.1016/J.Biopsych.2018.02.600 |
0.534 |
|
2017 |
Johnson MW, Garcia-Romeu A, Johnson PS, Griffiths RR. An online survey of tobacco smoking cessation associated with naturalistic psychedelic use. Journal of Psychopharmacology (Oxford, England). 269881116684335. PMID 28095732 DOI: 10.1177/0269881116684335 |
0.731 |
|
2017 |
Garcia-Romeu A, Griffiths RR, Johnson MW. Psychedelic-associated addiction remission: An online survey Drug and Alcohol Dependence. 171: e69. DOI: 10.1016/J.Drugalcdep.2016.08.199 |
0.542 |
|
2016 |
Garcia-Romeu A, Kersgaard B, Addy PH. Clinical applications of hallucinogens: A review. Experimental and Clinical Psychopharmacology. 24: 229-68. PMID 27454674 DOI: 10.1037/Pha0000084 |
0.309 |
|
2016 |
Johnson MW, Garcia-Romeu A, Griffiths RR. Long-term follow-up of psilocybin-facilitated smoking cessation. The American Journal of Drug and Alcohol Abuse. 1-6. PMID 27441452 DOI: 10.3109/00952990.2016.1170135 |
0.676 |
|
2015 |
Addy PH, Garcia-Romeu A, Metzger M, Wade J. The subjective experience of acute, experimentally-induced Salvia divinorum inebriation. Journal of Psychopharmacology (Oxford, England). 29: 426-35. PMID 25691501 DOI: 10.1177/0269881115570081 |
0.338 |
|
2015 |
Garcia-Romeu AP, Noorani T, Griffiths RR, Johnson MW. Long-term follow-up of psilocybin-facilitated smoking cessation: Abstinence outcomes and qualitative analysis of participant accounts Drug and Alcohol Dependence. 156: e78. DOI: 10.1016/J.Drugalcdep.2015.07.1130 |
0.591 |
|
2015 |
Garcia-Romeu AP, Griffiths RR, Johnson MW. Psychedelic-facilitated smoking cessation: An online survey Drug and Alcohol Dependence. 146: e120. DOI: 10.1016/J.Drugalcdep.2014.09.245 |
0.594 |
|
2015 |
Himelstein S, Saul S, Garcia-Romeu A. Does Mindfulness Meditation Increase Effectiveness of Substance Abuse Treatment with Incarcerated Youth? A Pilot Randomized Controlled Trial Mindfulness. 6: 1472-1480. DOI: 10.1007/S12671-015-0431-6 |
0.322 |
|
2014 |
Garcia-Romeu A, Griffiths RR, Johnson MW. Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction. Current Drug Abuse Reviews. 7: 157-64. PMID 25563443 DOI: 10.2174/1874473708666150107121331 |
0.689 |
|
2014 |
Johnson MW, Garcia-Romeu A, Cosimano MP, Griffiths RR. Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. Journal of Psychopharmacology (Oxford, England). 28: 983-92. PMID 25213996 DOI: 10.1177/0269881114548296 |
0.693 |
|
2014 |
Garcia-Romeu AP, Johnson MW, Griffiths RR. Examining the psychological mechanisms of psilocybin-assisted smoking cessation treatment: A pilot study Drug and Alcohol Dependence. 140: e66. DOI: 10.1016/J.Drugalcdep.2014.02.200 |
0.574 |
|
Show low-probability matches. |